Roche
RO.SW
#41
Rank
NZ$563.79 B
Marketcap
NZ$708.63
Share price
-0.06%
Change (1 day)
32.49%
Change (1 year)

Market capitalization of Roche (RO.SW)

Market cap: NZ$563.79 Billion

As of May 2026 Roche has a market cap of NZ$563.79 Billion. This makes Roche the world's 41th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Roche from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$563.79 B-1.28%
2025NZ$571.12 B42.03%
2024NZ$402.11 B8.49%
2023NZ$370.65 B-9.33%
2022NZ$408.80 B-22.36%
2021NZ$526.52 B26.97%
2020NZ$414.68 B1.06%
2019NZ$410.33 B30.67%
2018NZ$314.02 B3.27%
2017NZ$304.08 B7.78%
2016NZ$282.13 B-19.01%
2015NZ$348.34 B17.82%
2014NZ$295.66 B2.02%
2013NZ$289.80 B-24.43%
2012NZ$383.47 B102.71%
2011NZ$189.17 B14.52%
2010NZ$165.19 B-19.39%
2009NZ$204.94 B-12.12%
2008NZ$233.21 B17.91%
2007NZ$197.78 B-20.59%
2006NZ$249.07 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$934.88 B 65.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$480.87 B-14.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$246.95 B-56.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$248.83 B-55.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$305.51 B-45.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$172.75 B-69.36%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$66.98 B-88.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$471.32 B-16.40%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$172.14 B-69.47%๐Ÿ‡ฌ๐Ÿ‡ง UK